Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.820
+0.110 (6.43%)
Mar 6, 2026, 4:00 PM EST - Market closed
Caribou Biosciences Employees
Caribou Biosciences had 147 employees as of December 31, 2024. The number of employees decreased by 11 or -6.96% compared to the previous year.
Employees
147
Change (1Y)
-11
Growth (1Y)
-6.96%
Revenue / Employee
$75,912
Profits / Employee
-$1,007,653
Market Cap
170.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Vaxart | 105 |
| Nkarta | 105 |
| Immunic | 90 |
| Tonix Pharmaceuticals Holding | 81 |
| Cartesian Therapeutics | 66 |
| Milestone Pharmaceuticals | 33 |
| Whitehawk Therapeutics | 22 |
CRBU News
- 1 day ago - Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 17 days ago - Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample - Business Wire
- 22 days ago - Caribou Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR® - GlobeNewsWire
- 3 months ago - Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 - GlobeNewsWire
- 4 months ago - Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today> - Benzinga
- 4 months ago - Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma - GlobeNewsWire